Evidence map›Paper›PMID 35541696›Full record

ArticleRSC advances2018

Dual-stimuli-responsive TiO

Zideng Dai, Xue-Zhi Song, Junkai Cao, Yunping He, Wen Wen, Xinyu Xu, Zhenquan Tan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Nanomedicine in Lung Cancer Immunotherapy.Frontiers in bioengineering and biotechnology · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zideng DaiSchool of Petroleum and Chemical Engineering, Dalian University of Technology Panjin 124221 P. R. China tanzq@dlut.edu.cn.
Xue-Zhi SongSchool of Petroleum and Chemical Engineering, Dalian University of Technology Panjin 124221 P. R. China tanzq@dlut.edu.cn.ORCID https://orcid.org/0000-0001-9574-1570
Junkai CaoSchool of Petroleum and Chemical Engineering, Dalian University of Technology Panjin 124221 P. R. China tanzq@dlut.edu.cn.
Yunping HeSchool of Petroleum and Chemical Engineering, Dalian University of Technology Panjin 124221 P. R. China tanzq@dlut.edu.cn.
Wen WenSchool of Petroleum and Chemical Engineering, Dalian University of Technology Panjin 124221 P. R. China tanzq@dlut.edu.cn.
Xinyu XuSchool of Petroleum and Chemical Engineering, Dalian University of Technology Panjin 124221 P. R. China tanzq@dlut.edu.cn.
Zhenquan TanSchool of Petroleum and Chemical Engineering, Dalian University of Technology Panjin 124221 P. R. China tanzq@dlut.edu.cn.ORCID https://orcid.org/0000-0002-1730-7290
Dalian University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biological applications of nanosheets are rapidly increasing currently, which introduces new possibilities to improve the efficacy of cancer chemotherapy and radiotherapy. Herein, we designed and synthesized a novel nano-drug system, doxorubicin (DOX) loaded titanium peroxide (TiO

Identifiers

PMID35541696
PMCPMC9081125
OpenAlexW2807740215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.